The arc of history bends to the innovators, the pioneers of possible who transform lives and forge new worlds. These innovators, enabled by great teams and visionary investors, inspire us. They are our purpose.
Third500 is building THE Emerging Growth Investment Bank — to embody the spirit of the innovator, to embrace their cause, and to empower them for the wonderous world they will create.
In a 2000-meter rowing contest, the third 500 meters is where the race is won. A long way from the start yet far from victory, the arduous third 500 is when teams become legends; When achievement is born of persistence. When potential yields reality. Where the best ideas become big businesses.
Through the success of 100 growth companies from over 40 countries, Third500 has advised on more than $3 billion in investment and strategic transactions. Since 2018, Third500 clients have raised $1.2 billion, created $3.2 billion in investment gains and generated 45% IRR after increasing value to legacy investors by 330%.
From Chicago to Shanghai, Austin to Amsterdam, Boston to Basel, Singapore to Sandhill, Third500 clients enjoy access to a global network of investors and acquirers throughout the Emerging Growth capital markets.
MyRepublic completes $90 million recapitalization to enable accelerated growth of leading integrated telecommunications services in Asia.
Since 2018, our clients have raised $1.2 billion and created $3.2 billion in investments gains after increasing value to their founders by 330% Proof Point
Nautilus Data Technologies has closed the first tranche of a $50 million private convertible financing led by UIL.
Xenex Disinfection Services has secured a $100 million Senior Debt facility to accelerate commercialized of its LightStrike technology.
Rapid Micro Biosystems completes $60 million equity financing to advance commercialization of its Growth Direct System.
Beginning in 2015, Liquidia Technologies raised $127.3 million in a series of private and public financing initiatives, worldwide.
Mobius Imaging completes. a series of financing initiatives with a $500 million acquisition by Stryker.
Eirion Therapeutics completes $40 million Series A financing led by Shanghai Haohai Biological Technology Ltd. to advance the development of its propriety topical neuromodulator treatment.
Third500 is a boutique investment bank serving the global Emerging Growth economy. Our firm was conceived to serve companies in their own” third 500”. The fastest growing, most dynamic companies in the world. Innovators at the peak of their potential. Proven businesses -- a long way from the start, yet far from victory. Great teams -- on the brink of history.
From the $10 million private placement to the $50 million IPO, the $75 million “pre-money” to the $300 million “target market cap,” the $15 million partnership to the $500 million M&A event.
We are distinguished by the market we serve and the things we do for the company we keep. And we’re just putting our oars in the water.
Send us your question and we will contact you shortly.